Product
Help
Pricing
About
Jobs
Log in
Get started
Institution
Add to collection
Madhavi Netralaya
Homepage:
madhavinetralaya.com
ROR:
02wgdvp71
OpenAlex ID:
I4405284077
Semaglutide and the risk of diabetic retinopathy—current perspective
2021
·
Ashish Sharma
, Nikulaa Parachuri
, et al.
·
Eye
·
54
PDF
Approved biosimilar ranibizumab—a global update
2022
·
Ashish Sharma
, Mineo Kondo
, et al.
·
Eye
·
50
Port delivery system with ranibizumab (Susvimo) recall- What does it mean to the retina specialists
2023
·
Ashish Sharma
, Arshad M. Khanani
, et al.
·
International Journal of Retina and Vitreous
·
47
PDF
Understanding Retinal Vasculitis Associated with Brolucizumab: Complex Pathophysiology or Occam’s Razor?
2021
·
Ashish Sharma
, Nilesh Kumar
, et al.
·
Ocular Immunology and Inflammation
·
40
PDF
Brolucizumab-related retinal vasculitis: emerging disconnect between clinical trials and real world
2020
·
Ashish Sharma
, Nilesh Kumar
, et al.
·
Eye
·
37
PDF
Biosimilars for retinal diseases: United States-Europe awareness survey (Bio-USER – survey)
2023
·
Ashish Sharma
, Frank G Holz
, et al.
·
Expert Opinion on Biological Therapy
·
30
PDF
Biosimilar Ranibizumab (Ranieyes) Safety and Efficacy in the Real World: BRESER Study
2025
·
Ashish Sharma
, Frank G. Holz
, et al.
·
Journal of VitreoRetinal Diseases
·
23
Anti-VEGF Biosimilars for Retinal Diseases Survey 2023- India (Bio-INDAS) by the International Retina Biosimilar Study Group (Inter-BIOS Group) in collaboration with the Vitreo-Retinal Society of India (VRSI)
2024
·
Ashish Sharma
, Peter K. Kaiser
, et al.
·
Eye
·
17
PDF
Ranizurel safety evaluation in real-world -(RaSER) study
2022
·
Ashish Sharma
, Jayshree Arunaprakash
, et al.
·
American Journal of Ophthalmology Case Reports
·
17
PDF
Biosimilar ranibizumab interchangeability: what does it mean to retinal physicians?
2022
·
Ashish Sharma
, Nilesh Kumar
, et al.
·
Eye
·
16
PDF
Biosimilar ranibizumab (BS1) – early experience from Japan (BRIJ study)
2024
·
Tomoko Ueda-Consolvo
, Masaaki Ishida
, et al.
·
Eye
·
15
PDF
The Port Delivery System with ranibizumab—journey of mitigating vitreous hemorrhage
2021
·
Ashish Sharma
, Nikulaa Parachuri
, et al.
·
Eye
·
15
PDF
Brolucizumab—early experience with early extended interval regime in chronic centre involved diabetic macular oedema
2021
·
Debdulal Chakraborty
, Soumen Mondal
, et al.
·
Eye
·
15
PDF
Biosimilar to Biosimilar Anti-VEGF Switching for Retinal Diseases
2023
·
Ashish Sharma
, Anat Loewenstein
, et al.
·
Journal of VitreoRetinal Diseases
·
14
PDF
On label bevacizumab for retina: where it stands
2022
·
Ashish Sharma
, Nilesh Kumar
, et al.
·
Eye
·
14
PDF
Management of Fluid in Neovascular Age-related Macular Degeneration: To Mop it, to Dab it, or to Leave it?
2020
·
Ashish Sharma
, Nilesh Kumar
, et al.
·
Retina
·
14
Global experience of faricimab in clinical settings - a review
2024
·
Ashish Sharma
, Nilesh Kumar
, et al.
·
Expert Opinion on Biological Therapy
·
12
Brolucizumab ─ termination of 4 weekly trials ─ rebalancing the immunogenicity risk
2022
·
Ashish Sharma
, Nilesh Kumar
, et al.
·
Expert Opinion on Biological Therapy
·
12
Aflibercept 2 mg biosimilars—will they lead the Anti-VEGF biosimilar world globally
2025
·
Ashish Sharma
, Se Joon Woo
, et al.
·
Eye
·
10
PDF
FYB-201 Biosimilar ranibizumab (Ongavia/Ranivisio/Cimerli) Efficacy and Safety in Clinical Settings – FORCE study
2025
·
Ashish Sharma
, Luke Nicholson
, et al.
·
Eye
·
8
Aflibercept 2 mg biosimilar (Tyalia)—real-world experience from IRAN (ATRIA study)
2025
·
Sahar Avadzadeh
, Ashish Sharma
, et al.
·
Eye
·
8
Biosimilar ranibizumab in India- overview of phase 3 clinical trial designs
2024
·
Ashish Sharma
, Nilesh Kumar
, et al.
·
Eye
·
8
PDF
Immunogenicity: Clouding the Future of Intravitreal Therapy
2022
·
Ashish Sharma
, Nilesh Kumar
, et al.
·
Ocular Immunology and Inflammation
·
8
PDF
Biosimilar anti-VEGF- is prefilled syringe (PFS) a challenge?
2023
·
Ashish Sharma
, Anat Loewenstein
, et al.
·
Eye
·
7
PDF
Fear of safety compromise with biosimilar anti-VEGF—perception or truth
2022
·
Ashish Sharma
, Nikulaa Parachuri
, et al.
·
Eye
·
7
PDF
Show more works
View as search
Works count:
55
Citation count:
561
Year
Topic
Type